Insider Trading: Pharma Employees Increasingly In SEC Crosshairs
Executive Summary
In past month, three individuals in biopharma space have been charged with insider trading despite efforts by companies and associations to protect confidential information; past sentencing suggests length of jail time former FDA official Gordon Johnston is likely to face.